` 0NN (Avicanna Inc) vs DAX Index Comparison - Alpha Spread

0NN
vs
D
DAX Index

Over the past 12 months, 0NN has underperformed DAX Index, delivering a return of -33% compared to the DAX Index's +14% growth.

Stocks Performance
0NN vs DAX Index

Loading
0NN
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
0NN vs DAX Index

Loading
0NN
DAX Index
Difference
www.alphaspread.com

Performance By Year
0NN vs DAX Index

Loading
0NN
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Avicanna Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Avicanna Inc
Glance View

Market Cap
3.7m EUR
Industry
Pharmaceuticals

Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario and currently employs 18 full-time employees. The company went IPO on 2019-07-18. The firm is engaged in cannabinoid research, development, and evidence-based products for the global consumer, as well as medical and pharmaceutical market segments. The firm's scientific platform commercializes over twenty products across four market segments: Medical Cannabis & Wellness Products, CBD Derma-Cosmetic Products, Pharmaceuticals and Cannabis Raw Materials, Seeds, and Bulk Formulations. Its Medical Cannabis & Wellness Products are an advanced line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC), marketed under the RHO Phyto brand. Its CBD Derma-Cosmetic Products are marketed under the Pura H&W or Pura Earth brands. Its cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.

0NN Intrinsic Value
0.232 EUR
Undervaluation 61%
Intrinsic Value
Price €0.091
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett